Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury
- PMID: 27857741
- PMCID: PMC5090840
- DOI: 10.4103/1673-5374.191212
Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury
Erratum in
-
Correction: Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury.Neural Regen Res. 2017 Feb;12(2):266. doi: 10.4103/1673-5374.200818. Neural Regen Res. 2017. PMID: 28400809 Free PMC article.
References
-
- Benyi E, Kieler H, Linder M, Ritzén M, Carlstedt-Duke J, Tuvemo T, Westphal O, Sävendahl L. Risks of malignant and non-malignant tumours in tall women treated with high-dose oestrogen during adolescence. Horm Res Paediatr. 2014;82:89–96. - PubMed
-
- Chakrabarti M, Das A, Samantaray S, Smith JA, Banik NL, Haque A, Ray SK. Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury. Rev Neurosci. 2016;27:271–281. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
